Vir Biotechnology, Inc. VIR Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s total equity?
- Vir Biotechnology, Inc. (VIR) reported total equity of $812.77M in Q1 2026.
- How has Vir Biotechnology, Inc.'s total equity changed year-over-year?
- Vir Biotechnology, Inc.'s total equity decreased by 22.1% year-over-year, from $1.04B to $812.77M.
- What is the long-term trend for Vir Biotechnology, Inc.'s total equity?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s total equity has grown at a 1.3% compound annual growth rate (CAGR), from $716.85M to $765.28M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.